Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2020 - 12 - 07    symbols : OCX    save search
Oncocyte Corporation Hosting Key Opinion Leader Call on Proprietary Molecular Tests for Cancer Treatment Selection
Published: 2020-12-07 (Crawled : 21:06) - globenewswire.com
OCX | News J | $2.495 -2.54% -2.61% 50K twitter stocktwits trandingview |
Health Technology
 | | O: 1.01% H: 6.0% C: 3.5%
cancer test molecular treatment
Gainers vs Losers
67% 33%

Top 10 Gainers
RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services
NYC 4 | $5.91 -4.83% 14.38% 770 twitter stocktwits trandingview |
Finance
GBR | $1.42 31.48% 11.27% 990K twitter stocktwits trandingview |
Energy Minerals
DEO | News | $140.76 -0.02% 8.27% 560K twitter stocktwits trandingview |
Consumer Non-Durables
KUKE | $2.88 2.49% 7.64% 360K twitter stocktwits trandingview |

LYT | $4.22 4.72% 5.62% 1.4M twitter stocktwits trandingview |

SYY | $76.73 1.44% 5.49% 2.5M twitter stocktwits trandingview |
Distribution Services
TWI | $11.53 0.96% 4.94% 330K twitter stocktwits trandingview |
Producer Manufacturing
BTCM | $1.99 -6.13% 4.52% 75K twitter stocktwits trandingview |
Arts, Entertainment, and Recrea...
MPLN | $0.6502 -11.74% 4.51% 2.2M twitter stocktwits trandingview |
Finance
Your saved searches
Save your searches and get alerts when important news are released.